Equities

avVaa World Health Care Products Inc

AVVH:PKC

avVaa World Health Care Products Inc

Actions
  • Price (USD)0.0013
  • Today's Change0.000 / 8.75%
  • Shares traded106.10k
  • 1 Year change-34.75%
  • Beta-1.5094
Data delayed at least 15 minutes, as of Nov 14 2024 16:46 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year avVaa World Health Care Products Inc grew revenues 142.40% from 13.49k to 32.70k while net income improved from a loss of 41.43k to a gain of 24.53k.
Gross margin95.92%
Net profit margin124.69%
Operating margin124.69%
Return on assets101.60%
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2013, cash reserves at avVaa World Health Care Products Inc fell by 410.00. However, the company earned 79.04k from its operations for a Cash Flow Margin of 241.71%. In addition the company used 75.50k on investing activities and also paid 3.95k in financing cash flows.
Cash flow per share0.00003
Price/Cash flow per share23.41
Book value per share-0.0069
Tangible book value per share-0.0069
More ▼

Balance sheet in USDView more

avVaa World Health Care Products Inc uses little or no debt in its capital structure.
Current ratio0.0007
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 150.00%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
200.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.